Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard D Thames

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancerSteven H Lin, Jing Zhang, Uma Giri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995Howard D Thames, Deborah Kuban, Larry B Levy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2006
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studiesAla Yaromina, Daniel Zips, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2010
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelSusan L Tucker, Lei Dong, Walter R Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Predicting radiosensitivity using DNA end-binding complex analysisSheikh M Ismail, Monica Puppi, Sheela Prithivirajsingh, et al.
Brachytherapy|September 16, 2023
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetryJeremiah W Sanders, Chad Tang, Rajat J Kudchadker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomyCherry T Thomas, Patrick T Bradshaw, Brad H Pollock, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?Julia L Oh, Mark Bonnen, Elesyia D Outlaw, et al.
Scientific Reports|December 24, 2017
Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold NanoparticlesAllison M Khoo, Sang Hyun Cho, Francisco J Reynoso, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2009
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapyZhongxing X Liao, Ritsuko R Komaki, Howard D Thames, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancerSteven H Lin, Jing Zhang, Uma Giri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995Howard D Thames, Deborah Kuban, Larry B Levy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2006
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studiesAla Yaromina, Daniel Zips, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2010
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelSusan L Tucker, Lei Dong, Walter R Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Predicting radiosensitivity using DNA end-binding complex analysisSheikh M Ismail, Monica Puppi, Sheela Prithivirajsingh, et al.
Brachytherapy|September 16, 2023
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetryJeremiah W Sanders, Chad Tang, Rajat J Kudchadker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomyCherry T Thomas, Patrick T Bradshaw, Brad H Pollock, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?Julia L Oh, Mark Bonnen, Elesyia D Outlaw, et al.
Scientific Reports|December 24, 2017
Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold NanoparticlesAllison M Khoo, Sang Hyun Cho, Francisco J Reynoso, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2009
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapyZhongxing X Liao, Ritsuko R Komaki, Howard D Thames, et al.
Pageof 8